Assyro AI

Orange Book product · Brand (NDA)

VOSTALLY

RAMIPRIL

Brand (NDA)NDA 219757DISCN ROSEMONT PHARMS

At a glance

Jul 23, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 23, 2025

    11 mo ago

  2. Today

  3. Patent 12343338 expires

    Listed drug product patent expiration.

    Aug 16, 2039

    in 13 yr 4 mo

Pharmaceutical detail

Active ingredient

RAMIPRIL

Strength

1MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 219757

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12343338Aug 16, 2039in 13 yr 4 mo
ProductU-4233
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.